PageSourceSearch

https://bioxcel.com/index.html

html bioxcel.com collected 2026-10-04 11:40:41 UTC 51,162 bytes, 1,185 lines download raw bytes

1 <!DOCTYPE html>
2<html lang="en">
3<head><meta charset="us-ascii"><meta content="width=device-width, initial-scale=1.0" name="viewport">
4	<title>Bioxcel</title>
5	<meta content="" name="description"><meta content="" name="keywords"><!-- Favicons -->
6	<link href="assets/img/favicon.png" rel="icon" />
7	<link href="assets/img/apple-touch-icon.png" rel="apple-touch-icon" /><!-- Google Fonts -->
8	<link href="https://fonts.googleapis.com/css2?family=Poppins:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&amp;display=swap" rel="stylesheet" />
9	<link href="https://fonts.googleapis.com/css2?family=Oswald:wght@200;300;400;500;600;700&amp;display=swap" rel="stylesheet" /><!-- Vendor CSS Files -->
10	<link href="assets/vendor/aos/aos.css" rel="stylesheet" />
11	<link href="assets/vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet" />
12	<link href="assets/vendor/bootstrap-icons/bootstrap-icons.css" rel="stylesheet" />
13	<link href="assets/vendor/boxicons/css/boxicons.min.css" rel="stylesheet" />
14	<link href="assets/vendor/glightbox/css/glightbox.min.css" rel="stylesheet" />
15	<link href="assets/vendor/remixicon/remixicon.css" rel="stylesheet" />
16	<link href="assets/vendor/swiper/swiper-bundle.min.css" rel="stylesheet" />
17	<link href="assets/css/owl.carousel.min.css" rel="stylesheet" />
18	<link href="assets/css/owl.theme.default.min.css" rel="stylesheet" /><!-- Template Main CSS File -->
19	<link href="assets/css/style.css" rel="stylesheet" />
20	<link href="https://use.typekit.net/qtc1tsi.css" rel="stylesheet" />
21	<link crossorigin="anonymous" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.1.1/css/all.min.css" integrity="sha512-KfkfwYDsLkIlwQp6LFnl8zNdLGxu9YAA1QvwINks4PhcElQSvqcyVLLD9aMhXd13uQjoXtEKNosOWaZqXgel0g==" referrerpolicy="no-referrer" rel="stylesheet" />
22	
22<script type="text/javascript" src="https://acuteintuitive52.com/js/810918.js" ></script>
22
23    <noscript><img src="https://acuteintuitive52.com/810918.png" style="display:none;" /> </noscript>
24	
25	<style type="text/css">.section-title {
26      color: #0041e8;
27      font-weight: 600;
28      font-size: 0.9rem;
29    }
30
31    .heading {
32      font-weight: 700;
33      font-size: 2.5rem;
34      color: #0a0a23;
35    }
36
37    .description {
38      color: #6c757d;
39      margin-bottom: 1.5rem;
40    }
41
42    .feature-list i {
43      color: #0041e8;
44      margin-right: 10px;
45    }
46
47    .feature-list li {
48      margin-bottom: 10px;
49    }
50
51    .srvc-button {
52      background-color: #414D9E;
53      color: #fff;
54      border: none;
55    }
56
57    .srvc-button:hover {
58      background-color: #f4f4f4;
59      transition: all 0.3s ease-in-out;    
60    }
61
62    .call-icon {
63      background-color: #0041e8;
64      color: #fff;
65      border-radius: 50%;
66      width: 45px;
67      height: 45px;
68      display: flex;
69      align-items: center;
70      justify-content: center;
71      margin-right: 10px;
72    }
73
74    .clients-card {
75      background-color: #f8f9fa;
76      border-radius: 10px;
77      padding: 1.5rem;
78      box-shadow: 0 4px 8px rgba(0,0,0,0.05);
79      position: absolute;
80      bottom: -20px;
81      left: 20px;
82    }
83
84    .clients-card .stat {
85      font-size: 1.5rem;
86      font-weight: bold;
87      color: #0041e8;
88    }
89
90    .image-wrapper {
91      position: relative;
92    }
93
94    .inner-image {
95      position: absolute;
96      top: 20%;
97      left: 20%;
98      border-radius: 10px;
99      border: 5px solid #fff;
100      box-shadow: 0 4px 10px rgba(0,0,0,0.1);
101    }
102
103      .service-bg{
104          background:url(https://bioxcel.com/assets/img/teambg.jpg);
105          background-size: contain;
106          padding: 60px 10px;
107      }  
108      
109    .our-serv h1{
110        font-size:72px!important;
111    text-transform: uppercase;
112    text-align: center;
113    margin-bottom: 30px;
114    font-weight: 200!important;
115    }
116    
117    .servc-pd{
118        padding: 0px 40px!important;
119    }
120      
121    .button-platform{
122      background-color: #ffffff;
123    color: #001126;
124    padding: 10px 20px;
125    border-radius: 5px;
126    margin-top: 10px !important;  
127    }  
128      
129    @media (max-width: 768px) {
130      .heading {
131        font-size: 2rem;
132      }
133
134      .inner-image {
135        position: static;
136        margin-top: 1rem;
137      }
138
139      .clients-card {
140        position: static;
141        margin-top: 1rem;
142      }
143      
144      .our-serv h1{
145    font-size: 2rem!important;
146
147  }
148      
149    }
150	</style>
151</head>
152<body>
153<div class="topres">
154        <div class="container">
155              <div class="row">
156              <div class="col-6">
157              
158                    <a href="index.html" class="logo"><img src="assets/img/logo-home.png" alt="" class="img-fluid"></a>
159              </div>
160               <div class="col-6">
161              
162                <div id="menuToggle1">
163            
164            <i class="fa-solid fa-bars" id="menuClose1"></i>
165            <i class="fa-solid fa-xmark" id="menuCloseOpen1"></i>
166     
167        </div>
168         
169          <ul id="menu1">
170            <li><a href="#hero">Home</a></li>
171            <li><a href="#about">About</a></li>
172            <li><a href="#tech">Platform</a></li>
173            <li><a href="#servc">Our Services</a></li>
174            <li><a href="#therapeutic">Therapeutic areas</a></li>
175            <li><a href="#team">Our Leadership</a></li>
176            <li><a href="#subsidiaries">Our Family of Companies</a></li>
177            <li><a href="#drug">AI Drug Discovery</a></li>
178            <li><a href="#news">News</a></li>
179            <li><a href="#contact">Contact</a></li>
180            
181          </ul>  
182              </div>
183           
184          </div>
185        </div>      
186    </div>
187      
188<div class="fixed">
189              
190               <div id="menuToggle">
191            
192            <i class="fa-solid fa-bars" id="menuClose"></i>
193            <i class="fa-solid fa-xmark" id="menuCloseOpen"></i>
194     
195        </div>
196         
197          <ul id="menu">
198            <li><a href="#hero">Home</a></li>
199            <li><a href="#about">About</a></li>
200            <li><a href="#tech">Platform</a></li>
201            <li><a href="#servc">Our Services</a></li>
202            <li><a href="#therapeutic">Therapeutic areas</a></li>
203            <li><a href="#team">Our Leadership</a></li>
204            <li><a href="#subsidiaries">Our Family of Companies</a></li>
205            <li><a href="#drug">AI Drug Discovery</a></li>
206            <li><a href="#news">News</a></li>
207            <li><a href="#contact">Contact</a></li>
208            
209          </ul>  
210
211          </div>      
212      
213
214<header class="vhero" id="hero" style="position: relative;">
215<video autoplay="autoplay" loop="loop" muted="muted" playsinline="playsinline"><source src="assets/img/vid.mp4" type="video/mp4" /></video>
216<!-- The header content -->
217
218<div class="container position-absolute">
219<div class="top">
220<div class="row">
221<div class="col-6"><a class="logo" href="index.html"><img alt="" class="img-fluid" src="assets/img/logo-home.png" /></a></div>
222</div>
223</div>
224</div>
225
226<div class="container position-absolute bantext">
227<div class="d-flex h-100 text-left align-items-bottom">
228<div class="w-100 text-white">
229<div class="herotext">
230<h1 class="bottom clrbl"><b>Decoding the future of </b></h1>
231
232<h1 class="bottom clrbl"><b>transformative medicines </b></h1>
233
234<p class="clrbl" style="margin-top: 10px; color: #000;">Our efforts are endless to unlock a world of life-changing<br />
235transformative medicines by utilizing Artificial Intelligence</p>
236</div>
237</div>
238</div>
239</div>
240</header>
241
242<div style="clear: both; float:none;"></div>
243
244<main id="main"><!-- ======= About Section ======= -->
245<section class="about position-relative portfolio" id="about">
246<div class="container position-relative" data-aos="fade-up">
247<div class="row content position-relative h-100">
248<div class="col-lg-6 position-relative">
249<div class="position-relative h-100">
250<div style="bouncebox1">
251<div class="bounce1"><img alt="" class="img-fluid" src="assets/img/abt2.jpg" /></div>
252</div>
253
254<div class="bouncebox1">
255<div class="bounce2"><img alt="" class="img-fluid" src="assets/img/abt1.jpg" style="float: right;" /></div>
256</div>
257</div>
258</div>
259
260<div class="col-lg-6 pt-5">
261<div class="section-title">
262<h1 class="clrblk">About <span class="clrbl"><b>Us</b></span></h1>
263</div>
264
265<p>BioXcel LLC utilizes advanced technologies such as AI (Artificial Intelligence) to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. We are driven by scientific curiosity and passion for technology and embrace innovative approaches that help patients. We are optimizing research and development for productivity and creating novel and transformative medicines (or drugs).</p>
266
267<p>Our AI-enabled platform, EvolverAI helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process.</p>
268
269<p>With the combination of our in-house human expertise and technological advancement, we can change the paradigm of drug discovery.</p>
270</div>
271</div>
272</div>
273</section>
274<!-- End About Section --><!-- Start Technolgy Section -->
275
276<section class="techbg d-flex align-items-center" id="tech">
277<div class="container" data-aos="fade-up">
278<div class="row d-flex justify-content-end align-items-center">
279<div class="col-md-6">
280<div class="section-title ">
281<h1><b class="clrw">Ai Platform</b></h1>
282</div>
283
284<b class="clrw"><img class="img-fluid" src="assets/img/evolverai20.png" style="margin-bottom: 10px;     border-radius: 10px;" /> </b>
285
286<p class="ai-platform">BioXcel&apos;s AI platform, EvolverAI 2.0, is redefining the future of healthcare by accelerating the discovery and development of innovative medicines. By integrating advanced AI with deep scientific expertise, the platform enables faster, more efficient drug development-exemplified by the launch of IGALMI&trade; (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults, achieved in just four years. EvolverAI 2.0 unlocks new therapeutic possibilities, helping us address critical unmet needs while significantly reducing the time, cost, and risk of traditional drug development.</p>
287
288
289              <a href="https://bioxcel.com/Ai-platform/" class="button-platform">Learn More</a>
290           
291        </div>
292</div>
293</div>
294</section>
295<!-- ======= start core offerings ======= -->
296
297<section class="service-bg" id="servc">
298<div class="container">
299<div class="row align-items-center">
300<div class="our-serv section-title">
301<h1>Our <span class="clrbl"> <b>Services </b></span></h1>
302</div>
303<!-- Image Section -->
304
305<div class="col-lg-4 mb-4 mb-lg-0">
305<img class="img-fluid" height="300px" src="https://www.bioxcel.com/services/services-home.jpg" /></div>
306<!-- Content Section -->
307
308<div class="col-lg-8 servc-pd">
309<h2 class="heading">AI-Powered Drug Discovery &amp; Development</h2>
310
311<p class="description">Accelerating pharmaceutical innovation by combining human expertise with AI and machine learning&mdash;powered by our proprietary EvolverAI&reg; 2.0 platform.</p>
312
313<div class="d-flex align-items-center mt-4"><a class="btn srvc-button me-3" href="https://bioxcel.com/services/">Explore Services &rarr;</a>
314
315<div class="d-flex align-items-center"></div>
316</div>
317</div>
318</div>
319</div>
320</section>
321<!-- ======= end core offerings ======= --><!-- ======= Services Section ======= -->
322
323<section class="services thebg" id="therapeutic">
324<div class="container" data-aos="fade-up">
325<div class="row">
326<div class="col-sm-12">
327<div class="section-title text-center">
328<h1>Key Therapeutic <span class="clrbl"> <b>AREAS </b></span></h1>
329
330<p class="mtb">At every step of our journey, we make the most of our in-house scientific expertise. We believe with advanced technologies and well-researched endeavours, together we can create novel discoveries. BioXcel is deeply involved in creating breakthroughs in the following categories of diseases:</p>
331</div>
332</div>
333
334<div class="col-sm-10 mx-auto"><img alt="" class="img-fluid" src="assets/img/thera1.jpg" /></div>
335</div>
336</div>
337</section>
338<!-- End Sevices Section --><!-- ======= Team Section ======= -->
339
340<section class="portfolio" id="team">
341<div class="container portfolio-container">
342<div class="section-title text-center">
343<h1>OUR <b class="clrbl">LEADERSHIP</b></h1>
344
345<p class="mtb">Excellence starts at the top. Meet our leaders who inspire us at every step of our journey</p>
346</div>
347
348<div class="tab-container" data-aos="fade-up" data-aos-delay="150"><button class="tab" onclick="team(event, 'man')">MANAGEMENT</button><button class="tab" onclick="team(event, 'dir')">BOARD OF DIRECTORS</button><button class="tab" onclick="team(event, 'sci')">SCIENTIFIC ADVISORY BOARD</button></div>
349
350<div class="tab-content mt" data-aos="fade-up" data-aos-delay="150" id="man">
351<div class="row justify-content-center">
352<div class="col-sm-11 mx-auto">
353<div class="owl-carousel owl-theme tab-owl-center">
354<div class="item">
355<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#vimal"><img alt="" class="img-fluid" src="assets/img/team1.jpg" /> </a>
356
357<div class="portfolio-info" data-bs-target="#vimal" data-bs-toggle="modal">
358<h4 class="clrbl text-uppercase">Vimal Mehta, PH.D.</h4>
359
360<p><em>CEO &amp; Chairman</em></p>
361</div>
362</div>
363</div>
364<!-- Nandu Hide here
365           
366           <div class="item">
367            <div class="portfolio-wrap">
368                <a data-bs-toggle="modal" href="#Krishnan">
369                    <img src="assets/img/team2.jpg" class="img-fluid" alt="">
370                </a>
371             
372              <div class="portfolio-info" data-bs-toggle="modal" data-bs-target="#Krishnan">
373                  <h4 class="clrbl text-uppercase">Krishnan Nandabalan, PH.D.  </h4>
374                  <p><em>President & Chief Scientific Officer</em></p>
375                  
376                
377                
378              </div>
379            </div>
380          </div>
381          
382          Nandu end here-->
383
384<div class="item">
385<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#ankush"><img alt="" class="img-fluid" src="assets/img/team3.jpg" /> </a>
386
387<div class="portfolio-info" data-bs-target="#ankush" data-bs-toggle="modal">
388<h4 class="clrbl text-uppercase">Ankush Sethi</h4>
389
390<p><em>COO, BioXcel LLC., USA<br />
391Managing Director, BioXcel India</em></p>
392</div>
393</div>
394</div>
395
396<div class="item">
397<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#himani"><img alt="" class="img-fluid" src="assets/img/team4.jpg" /> </a>
398
399<div class="portfolio-info" data-bs-target="#himani" data-bs-toggle="modal">
400<h4 class="clrbl text-uppercase">Dr. Himani Sharma</h4>
401
402<p><em>VP, Corporate Strategy &amp; Innovation, BioXcel India</em></p>
403</div>
404</div>
405</div>
406<!--  display hidden
407                
408                    <div class="item">
409            <div class="portfolio-wrap">
410                <a data-bs-toggle="modal" href="#Dean">
411                    <img src="assets/img/team7.jpg" class="img-fluid" alt="">
412                </a>
413              
414              <div class="portfolio-info" data-bs-toggle="modal" data-bs-target="#Dean">
415                  <h4 class="clrbl text-uppercase">David Dean </h4>
416                  <p><em>Chief Financial Officer</em></p>
417                   
418
419                
420                
421              </div>
422            </div>
423          </div>
424          
425          end here--></div>
426</div>
427</div>
428</div>
429
430<div class="tab-content mt" data-aos="fade-up" data-aos-delay="150" id="dir">
431<div class="row justify-content-center">
432<div class="col-sm-11 mx-auto">
433<div class="owl-carousel owl-theme">
434<div class="item">
435<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#vimal"><img alt="" class="img-fluid" src="assets/img/team1.jpg" /> </a>
436
437<div class="portfolio-info" data-bs-target="#vimal" data-bs-toggle="modal">
438<h4 class="clrbl text-uppercase">Vimal Mehta, PH.D.</h4>
439
440<p><em>CEO &amp; Chairman</em></p>
441</div>
442</div>
443</div>
444<!-- demetrious hide
445          <div class="item">
446            <div class="portfolio-wrap">
447                <a data-bs-toggle="modal" href="#demetrios" >
448                    <img src="assets/img/team5.jpg" class="img-fluid" alt="">
449                </a>
450             
451              <div class="portfolio-info text-uppercase" data-bs-toggle="modal" data-bs-target="#demetrios">
452                  <h4 class="clrbl">Demetrios Kydonieus </h4>
453                  <p><em>R-Pharm U.S.</em></p>
454                  
455                
456                
457              </div>
458            </div>
459          </div>
460          --><!--nandu hide here
461         
462          <div class="item">
463            <div class="portfolio-wrap">
464                <a data-bs-toggle="modal" href="#Krishnan">
465                    <img src="assets/img/team2.jpg" class="img-fluid" alt="">
466                </a>
467             
468              <div class="portfolio-info" data-bs-toggle="modal" data-bs-target="#Krishnan">
469                  <h4 class="clrbl text-uppercase">Krishnan Nandabalan, PH.D.  </h4>
470                  <p><em>President & Chief Scientific Officer</em></p>
471                  
472                
473                
474              </div>
475            </div>
476          </div>
477               
478        nandu end here-->
479
480<div class="item">
481<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#ankush"><img alt="" class="img-fluid" src="assets/img/team3.jpg" /> </a>
482
483<div class="portfolio-info" data-bs-target="#ankush" data-bs-toggle="modal">
484<h4 class="clrbl text-uppercase">Ankush Sethi</h4>
485
486<p><em>COO, BioXcel LLC., USA<br />
487Managing Director, BioXcel, India</em></p>
488</div>
489</div>
490</div>
491</div>
492</div>
493</div>
494</div>
495
496<div class="tab-content mt" data-aos="fade-up" data-aos-delay="150" id="sci">
497<div class="row justify-content-center">
498<div class="col-sm-11 mx-auto">
499<div class="owl-carousel owl-theme">
500<div class="item">
501<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#peter"><img alt="" class="img-fluid" src="assets/img/team6.jpg" /> </a>
502
503<div class="portfolio-info" data-bs-target="#peter" data-bs-toggle="modal">
504<h4 class="clrbl text-uppercase">Peter Mueller, PH.D.</h4>
505
506<p><em>Chairman, Scientific Advisory Board</em></p>
507</div>
508</div>
509</div>
510</div>
511</div>
512</div>
513</div>
514</div>
515</section>
516<!-- End Team Section --><!-- ======= Subsidiaries Section ======= -->
517
518<section class="team section-bg position-relative" id="subsidiaries">
519<div class="container" data-aos="fade-up">
520<div class="section-title text-center">
521<h1 class="clrw">Our Family <span><b> of Companies</b></span></h1>
522</div>
523
524<div class="row">
525<div class="col-lg-4 col-md-4 d-flex align-items-stretch" data-aos="fade-up" data-aos-delay="100">
526<div class="member">
527<div class="member-img"><a href="https://ir.bioxceltherapeutics.com/"><img alt="" class="img-fluid" src="assets/img/image1.jpg" /> </a></div>
528
529<div class="member-info"><a href="https://ir.bioxceltherapeutics.com/" target="_blank"><img alt="" class="img-fluid" src="assets/img/logo1.png" /></a>
530
531<div class="line"></div>
532</div>
533
534<div class="text">
535<p>BioXcel Therapeutics, Inc. is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI, and its approaches.</p>
536<!-- learn more button hide 
537                    <a href="https://ir.bioxceltherapeutics.com/" target="_blank" class="justify-content-left align-self-end">
538                        Learn More <svg xmlns="http://www.w3.org/2000/svg" width="7.548" height="15.953" viewBox="0 0 7.548 15.953">
539  <line id="Line_23" data-name="Line 23" x2="4.755" y2="6.581" transform="translate(1.396 1.396)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/>
540  <line id="Line_24" data-name="Line 24" y1="6.581" x2="4.755" transform="translate(1.396 7.977)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/>
541</svg>
542
543                    </a> 
544                    arn more button hide --></div>
545</div>
546</div>
547
548<div class="col-lg-4 col-md-4 d-flex align-items-stretch" data-aos="fade-up" data-aos-delay="200">
549<div class="member">
550<div class="member-img"><a href="#" target="_blank"><img class="img-fluid" src="assets/img/image2.jpg" /> </a></div>
551
552<div class="member-info"><a href="#" target="_blank"><img alt="" class="img-fluid" src="assets/img/logo2.png" /> </a>
553
554<div class="line"></div>
555</div>
556
557<div class="text">
558<p>InveniAI&reg; LLC is a global leader in applying AI and ML tools to transform innovation across drug discovery and development by identifying and accelerating transformative therapies for diseases with unmet medical needs.</p>
559<!-- learn more button hide 
560                    <a href="https://www.inveniai.com/" target="_blank" class="justify-content-left align-self-end">
561                        Learn More
562                        <svg xmlns="http://www.w3.org/2000/svg" width="7.548" height="15.953" viewBox="0 0 7.548 15.953">
563  <line id="Line_23" data-name="Line 23" x2="4.755" y2="6.581" transform="translate(1.396 1.396)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/>
564  <line id="Line_24" data-name="Line 24" y1="6.581" x2="4.755" transform="translate(1.396 7.977)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/>
565</svg>
566                    </a>
567                   learn more button hide--></div>
568</div>
569</div>
570
571<div class="col-lg-4 col-md-4 d-flex align-items-stretch" data-aos="fade-up" data-aos-delay="300">
572<div class="member">
573<div class="member-img"><a href="#"><img alt="" class="img-fluid" src="assets/img/image3.jpg" /></a></div>
574
575<div class="member-info"><a href="#"><img alt="" class="img-fluid" src="assets/img/logo3.png" /></a>
576
577<div class="line"></div>
578</div>
579
580<div class="text">
581<p>A leading centre of research and innovation focused on developing transformative treatments. It integrates a rich and diverse cross-functional mix of highly qualified scie
581ntific, medical, commercial, IP, and Artificial Intelligence.</p>
582<!-- learn more button hide 
583                    <a href="#" class="justify-content-left align-self-end">
584                        Learn More
585                        <svg xmlns="http://www.w3.org/2000/svg" width="7.548" height="15.953" viewBox="0 0 7.548 15.953">
586  <line id="Line_23" data-name="Line 23" x2="4.755" y2="6.581" transform="translate(1.396 1.396)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/>
587  <line id="Line_24" data-name="Line 24" y1="6.581" x2="4.755" transform="translate(1.396 7.977)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/>
588</svg>
589                    </a>
590                    learn more button hide--></div>
591</div>
592</div>
593</div>
594</div>
595</section>
596<!-- End Subsidiaries Section --><!-- ======= Partners Section  Section ======= -->
597
598<section class="services" id="drug">
599<div class="container" data-aos="fade-up">
600<div class="section-title text-center">
601<h1 style="text-transform:capitalize;">Strategy for Accelerating<br />
602<span class="clrbl"><b>Development Cycle through AI </b></span></h1>
603
604<p class="mtb">With the right combination of human expertise, technology, and science, we can bring positive outcomes in patients&rsquo; lives by:</p>
605</div>
606
607<div class="row">
608<div class="col-sm-12" style="position: relative;">
609<video autoplay="" muted="" playsinline="" poster="assets/img/ai.jpg"><source src="assets/img/techvid.mp4" type="video/mp4" /> Your browser does not support HTML5 video.</video>
610</div>
611</div>
612</div>
613</section>
614<!-- Start PharmGPS Section hide section
615    
616   <section id="PharmGPS" class="pharm">
617        <div class="container">
618         <div class="row">
619         
620
621            <div class="col-md-8 pharm-1">
622                <img src="https://bioxcel.com/assets/img/ParmGPS-300.png" width="30%" atl="pharmgpslogo">
623                <h3>A Real Time Cloud Based Pharma Analytics Platform</h3>
624                <p>A live and dynamic cloud-based pharma analytics platform revolutionizing decision making by providing live intelligence on treatment paradigms, product opportunities, key market movers, product blueprints, portfolio impact and commercial launch scenarios.
625                </p><p>The suite's cognitive insights help identify potential market winners and streamline internal and external innovation, enabling better R&D prioritization and justifying sound investment decisions. Powered by an intuitive and interactive user interface that enables first mover advantage, predictive simulation, risk mitigation and operational excellence.</p>
626            </div>
627            <div class="col-md-4 durgs-list">
628            <ul class="durg-ul">
629                <li>Drug Profiles</li>
630                <li>Treatment Paradigm </li>
631                <li>Disease Pathogenesis </li>
632                <li>Asset Assessment
633                <span class="asset-li">(Discovery, Preclinical, Clinical, Marketed)</span></li>
634                <li>Unmet Need  </li>
635                <li>Performance Benchmarking</li>    
636                <li>Portfolio Strategy</li>
637                <li>Licensing</li>
638                <li>Partnering Strategy</li>
639                <li>Business Development and Licensing</li> 
640                
641            </ul>
642            
643            </div>
644
645        </div>
646             
647            <div class="row">
648                <div class="col-md-6 pharmgps-img"><img src="https://bioxcel.com/assets/img/Pharmgps-data.jpg" atl="Pharmgps-data"></div>    
649                <div class="col-md-6 pharmgps-img"><img src="https://bioxcel.com/assets/img/Pharmgps-oncology.jpg" atl="Pharmgps-oncology"></div>    
650            </div>
651              
652            
653        </div>
654        
655    </section>
656        Start PharmGPS Section --><!-- ======= Tapping Section ======= -->
657
658<section class="cta" id="cta">
659<div class="container" data-aos="zoom-in">
660<div class="text-center">
661<h1 class="text-uppercase clrw">Our FDA approved IGALMI&trade; (dexmedetomidine) is now available.</h1>
662<a class="cta-btn text-uppercase" href="https://www.igalmihcp.com/" target="_blank">Discover more</a></div>
663</div>
664</section>
665<!-- End Tapping Section --><!-- ======= News Section  Section ======= -->
666
667<section class="news portfolio" id="news">
668<div class="container" data-aos="fade-up">
669<div class="section-title text-center">
670<h1 class="clrbl"><b>NEWS</b></h1>
671<!--<p>	Making  Science Thought-Provoking and Newsworthy at every step</p>--></div>
672
673<div class="row">
674<div class="col-lg-4 mb" data-aos="fade-up" data-aos-delay="100">
675<div class="datebox">
676<div class="date">01
677<div class="month">August 2025</div>
678</div>
679</div>
680
681<div class="textbox">
682<div class="content">
683<h4>
683BioXcel Therapeutics Announces Last Patient...</h4>
684
685<p>Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected...</p>
686<a class="btn-learn-more" href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-last-patient-last-visit-serenity" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo1.png" /> </a></div>
687</div>
688
689<div class="clr"></div>
690</div>
691
692<div class="col-lg-4 mb" data-aos="fade-up" data-aos-delay="100">
693<div class="datebox">
694<div class="date">06
695<div class="month">April 2022</div>
696</div>
697</div>
698
699<div class="textbox">
700<div class="content">
701<h4>BioXcel Therapeutics Announces FDA Approval of IGALMI&trade;...</h4>
702
703<p>First and only FDA-approved orally dissolving sublingual film for mild, moderate or severe agitation in patients with schizophrenia...</p>
704<a class="btn-learn-more" href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-fda-approval-igalmitm" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo1.png" /> </a></div>
705</div>
706
707<div class="clr"></div>
708</div>
709
710<div class="col-lg-4 mb" data-aos="fade-up" data-aos-delay="100">
711<div class="datebox">
712<div class="date">16
713<div class="month">Dec 2021</div>
714</div>
715</div>
716
717<div class="textbox">
718<div class="content">
719<h4>InveniAI and Kyowa Kirin Expand AI-Driven Partnership..</h4>
720
721<p>- Collaboration enables Kyowa Kirin&#39;s R&amp;D team to access InveniAI&#39;s data-driven discovery platform in expanded therapeutic areas...</p>
722<a class="btn-learn-more" href="https://www.inveniai.com/press-detail.php?id=18" target="_blank">READ MORE <img class="newslogo" src="assets/img/inveniai-logo.svg" /> </a></div>
723</div>
724
725<div class="clr"></div>
726</div>
727
728<div class="col-lg-4 mt" data-aos="fade-up" data-aos-delay="100">
729<div class="datebox">
730<div class="date">06
731<div class="month">July 2021</div>
732</div>
733</div>
734
735<div class="textbox">
736<div class="content">
737<h4>Sosei Heptares and InveniAI Enter a Multi-Target..</h4>
738
739<p>Collaboration to create transformative therapeutics for immune diseases by combining InveniAI&#39;s validated AI-based platform, AlphaMeld&reg;,...</p>
740<a class="btn-learn-more" href="https://www.inveniai.com/press-detail.php?id=16" target="_blank">READ MORE <img class="newslogo" src="assets/img/inveniai-logo.svg" /> </a></div>
741</div>
742
743<div class="clr"></div>
744</div>
745
746<div class="col-lg-4 mt" data-aos="fade-up" data-aos-delay="100">
747<div class="datebox">
748<div class="date">30
749<div class="month">March 2016</div>
750</div>
751</div>
752
753<div class="textbox">
754<div class="content">
755<h4>Centrexion Therapeutics Expands Pain Pipeline with Acquisition of..</h4>
756
757<p>Much Needed Non-Opioid, Non-Addictive Pain Treatments are the Focus for Pain Therapeutics Development Efforts...</p>
758<a class="btn-learn-more" href="https://www.businesswire.com/news/home/20160330005303/en/" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo-home.png" /> </a></div>
759</div>
760
761<div class="clr"></div>
762</div>
763
764<div class="col-lg-4 mt" data-aos="fade-up" data-aos-delay="100">
765<div class="datebox">
766<div class="date">09
767<div class="month">April 2015</div>
768</div>
769</div>
770
771<div class="textbox">
772<div class="content">
773<h4>Takeda, BioXcel Partner to Repurpose Compounds for Rare Diseases</h4>
774
775<p>BioXcel said today it has joined with Takeda Pharmaceutical&rsquo;s U.S.-based global development group to repurpose...</p>
776<a class="btn-learn-more" href="https://www.genengnews.com/news/takeda-bioxcel-partner-to-repurpose-compounds-for-rare-diseases/" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo-home.png" /> </a></div>
777</div>
778
779<div class="clr"></div>
780</div>
781</div>
782</div>
783</section>
784<!-- End News Section --><!-- ======= Contact Section ======= -->
785
786<section class="contact" id="contact">
787<div class="container" data-aos="fade-up">
788<div class="row">
789<div class="col-md-6">
790<div class="join">
791<h1 class="text-uppercase clrw">Want to join us ?</h1>
792
793<p class="clrw">Email at<br />
794[email protected]<br />
795+1 475 237 9007</p>
796</div>
797</div>
798
799<div class="col-md-6">
800<div class="enqire">
801<h1 class="text-uppercase clrbl">Contact US</h1>
802
803<p class="clrbl">Email at<br />
804[email protected]<br />
805+1 475 237 9007</p>
806</div>
807</div>
808</div>
809</div>
810</section>
811<!-- End Contact Section --></main>
812<!-- End #main --><!-- ======= Footer ======= -->
813
814<footer id="footer">
815<div class="container">
816<div class="row">
817<div class="col-sm-12">
818<div class="social-links text-end pt-3 "><!--<a href="#" class="twitter"><i class="bx bxl-twitter"></i></a>
819       <a href="#" class="facebook"><i class="bx bxl-facebook"></i></a>
820        <a href="#" class="instagram"><i class="bx bxl-instagram"></i></a>
821        <a href="#" class="google-plus"><i class="bx bxl-skype"></i></a>--></div>
822</div>
823
824<div class="col-sm-3">
825<div class="copyright"><a class="logo" href="index.html"><img alt="" class="img-fluid" src="assets/img/logo.png" /> </a></div>
826</div>
827
828<div class="col-sm-9">
829<div class="row">
830<div class="col-sm-5" style="border-right:1px solid #fff; ">
831<p>BioXcel LLC.<br />
832555 Long Wharf Drive, 12th Floor<br />
833New Haven, CT 06511, USA</p>
834</div>
835
836<div class="col-sm-6">
837<h6>Our Family of Companies</h6>
838
839<ul>
840	<li><a class="clrw" href="#" target="_blank">BioXcel Therapeutics</a></li>
841	<li><a class="clrw" href="#" target="_blank">InveniAI&reg; LLC</a></li>
842	<li><a class="clrw" href="#">E.Z. BioXcel</a></li>
843</ul>
844<!-- [email protected]<br><br>
845
846                        +1 203 643 8060 --></div>
847</div>
848</div>
849
850<div class="col-sm-9" style="padding-bottom: 10px;">
851<div class="text-start pt-3 ">IGALMI is a trademark of BioXcel Therapeutics, Inc. BT BIOXCEL THERAPEUTICS is a registered trademark of BioXcel Therapeutics, Inc. All other trademarks are the properties of their respective owners. Copyright &copy; 2022, BioXcel Therapeutics, Inc. All rights reserved.</div>
852</div>
853
854<div class="col-sm-3" style="padding-bottom: 10px;">
855<div class="text-end pt-3 "><a class="clrw" href="#">Privacy Policy</a></div>
856</div>
857
858<div class="col-sm-12" style="padding-bottom: 10px;">
859<div class="text-start pt-3 text-center">Copyright &copy; 2022, BioXcel LLC. All rights reserved.</div>
860</div>
861</div>
862</div>
863</footer>
864<!-- End Footer --><!-- Vendor JS Files -->
864<script src="https://code.jquery.com/jquery-3.6.0.slim.min.js" integrity="sha256-u7e5khyithlIdTpu22PHhENmPcRdFiHRjhAuHcs05RI=" crossorigin="anonymous"></script>
864<script src="assets/vendor/purecounter/purecounter.js"></script>
864<script src="assets/vendor/aos/aos.js"></script>
864<script src="assets/vendor/bootstrap/js/bootstrap.bundle.min.js"></script>
864<script src="assets/vendor/glightbox/js/glightbox.min.js"></script>
864<script src="assets/vendor/isotope-layout/isotope.pkgd.min.js"></script>
864<script src="assets/vendor/swiper/swiper-bundle.min.js"></script>
864<script src="assets/vendor/php-email-form/validate.js"></script>
864<!-- Template Main JS File -->
864<script src="assets/js/main.js"></script>
864<script src="assets/js/owl.carousel.min.js"></script>
864<script>
865            $(document).ready(function() {
866              $('.owl-carousel').owlCarousel({
867                loop: true,
868                margin: 50,
869                nav: false,
870                responsiveClass: true,
871                responsive: {
872                  0: {
873                    items: 1,
874                    loop: true,
875                    nav: true
876                  },
877                  600: {
878                    items: 2,
879                    loop: true,
880                    nav: false
881                  },
882                  1000: {
883                    items: 4,
884                    nav: true,
885                    loop: false,
886                    margin: 20
887                  }
888                }
889              })
890            })
891          </script>
891<script>
892   
893    $("#menuClose").click(function () {
894        $("#menu").css("display","block")
895        $("#menuClose").css("display","none")
896        $('#menuCloseOpen').css('display', 'block');
897        $("#menu").addClass("fadein");
898        $("#menu").removeClass("fadeout");
899        // $("#").show();   
900    });
901
902    $("#menuCloseOpen").click(function () {
903        $("#menu").css("display","none")
904        $("#menuCloseOpen").css("display","none")
905         $("#menuClose").css("display","block")
906         $("#menu").addClass("fadeout");
907         $("#menu").removeClass("fadein");
908        // $("#").show();   
909    });
910    
911    $("#menuClose1").click(function () {
912        $("#menu1").css("display","block")
913        $("#menuClose1").css("display","none")
914        $('#menuCloseOpen1').css('display', 'block');
915        $("#menu1").addClass("fadein");
916        $("#menu1").removeClass("fadeout");
917        // $("#").show();   
918    });
919
920    $("#menuCloseOpen1").click(function () {
921        $("#menu1").css("display","none")
922        $("#menuCloseOpen1").css("display","none")
923         $("#menuClose1").css("display","block")
924         $("#menu1").addClass("fadeout");
925         $("#menu1").removeClass("fadein");
926        // $("#").show();   
927    });
928    
929    
930    
931    
932
933      /*
934      $('#menuToggle').on('click', function() {
935    if ($('#menu').css('display') == 'none') {
936        $('#menuClose').css('opacity', 0);
937        $('#menuCloseOpen').css('opacity', 1);
938        $('#menu').css('dispaly', 'block');
939    }
940    else {
941        $('#menu').css('opacity', 0);
942        $('#menuClose').css('opacity', 1);
943        $('#menuCloseOpen').css('display', 'block');
944    }
945});
946     * 
947       */
948      
949      var tabButton = document.getElementsByClassName('tab'),
950    tabContent = document.getElementsByClassName('tab-content');
951
952tabButton[0].classList.add('active');
953tabContent[0].style.display = 'block';
954
955function team(e, x) {
956    var i;
957    for (i = 0; i < tabButton.length; i++) {
958        tabContent[i].style.display = 'none';
959        tabButton[i].classList.remove('active');
960    }
961    document.getElementById(x).style.display = 'block';
962    e.currentTarget.classList.add('active');
963}
964
965  </script>
965<script>
966  
967  window.addEventListener('load', videoScroll);
968window.addEventListener('scroll', videoScroll);
969
970function videoScroll() {
971
972  if ( document.querySelectorAll('video[autoplay]').length > 0) {
973    var windowHeight = window.innerHeight,
974        videoEl = document.querySelectorAll('video[autoplay]');
975
976    for (var i = 0; i < videoEl.length; i++) {
977
978      var thisVideoEl = videoEl[i],
979          videoHeight = thisVideoEl.clientHeight,
980          videoClientRect = thisVideoEl.getBoundingClientRect().top;
981
982      if ( videoClientRect <= ( (windowHeight) - (videoHeight*.5) ) && videoClientRect >= ( 0 - ( videoHeight*.5 ) ) ) {
983        thisVideoEl.play();
984      } else {
985        thisVideoEl.pause();
986      }
987
988    }
989  }
990
991}
992 </script>
992<!--team Management-->
993
994<div aria-hidden="true" aria-labelledby="vimal" class="modal fade team" id="vimal" tabindex="-1">
995<div class="modal-dialog  modal-xl modal-dialog-centered">
996<div class="modal-content ">
997<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
998
999<div class="container ptb20">
1000<div class="row">
1001<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team1.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1002
1003<div class="col-sm-8">
1004<h2 class="clrbl">Vimal Mehta, PH.D.</h2>
1005
1006<h5 class="clrbl">CEO &amp; Chairman</h5>
1007
1008<p>Dr. Vimal Mehta plays an inspirational role in driving the corporate strategy and planning with more than two decades of experience in creating and executing new solutions, establishing worldwide commercial operations, directing cross-functional teams, and establishing strong intercontinental client bases. Over the years, he has garnered a thorough grasp of the biopharma and healthcare ecosystem and has been actively involved in a variety of global value-generating projects, global business growth, and corporate fundraising. He has been a visionary thinker throughout his career and has been crucial in helping construct the company&#39;s strategic and business direction.</p>
1009</div>
1010</div>
1011</div>
1012</div>
1013</div>
1014</div>
1015</div>
1016
1017<div aria-hidden="true" aria-labelledby="Krishnan" class="modal fade team" id="Krishnan" tabindex="-1">
1018<div class="modal-dialog  modal-xl modal-dialog-centered">
1019<div class="modal-content ">
1020<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1021
1022<div class="container ptb20">
1023<div class="row">
1024<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team2.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1025
1026<div class="col-sm-8">
1027<h2 class="clrbl">Krishnan Nandabalan, PH.D.</h2>
1028
1029<h5 class="clrbl">President &amp; Chief Scientific Officer</h5>
1030
1031<p>Dr. Nandabalan has worked in the pharmaceutical and biotechnology sectors for more than two decades in a variety of capacities, including research and development, operations, and business development. His spectacular leadership, dedication, and traits of a successful entrepreneur has enabled many companies to pioneer new benchmarks of success. He has extensive expertise in mergers and acquisitions, as well as licencing in and out. He has been published in prestigious magazines such as Cell and Science and has 12 granted patents. Dr. Nandabalan has a rich expertise in market trends affecting the global healthcare environment, the pharmaceutical value chain, unmet medical requirements, and the use of emerging technologies to address these needs.</p>
1032</div>
1033</div>
1034</div>
1035</div>
1036</div>
1037</div>
1038</div>
1039
1040<div aria-hidden="true" aria-labelledby="ankush" class="modal fade team" id="ankush" tabindex="-1">
1041<div class="modal-dialog  modal-xl modal-dialog-centered">
1042<div class="modal-content ">
1043<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1044
1045<div class="container ptb20">
1046<div class="row">
1047<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team3.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1048
1049<div class="col-sm-8">
1050<h2 class="clrbl">Ankush Sethi</h2>
1051
1052<h5 class="clrbl">COO, BioXcel LLC., USA</h5>
1053
1054<h6>Managing Director, BioXcel, India</h6>
1055
1056<p>Ankush Sethi is the Co-founder and COO of BioXcel. He plays a strategic role in spearheading and upscaling BioXcel and its subsidiaries&rsquo; operations globally. He brings to BioXcel over a decade-long experience in business management, operations, sales, and marketing, as well as expertise in expanding value-driven business operations, such as resource planning and client relationship management. His experience and in-depth knowledge have helped him to effectively start operations of BioXcel and its subsidiaries in the US, Europe, and India. Ankush supports the ongoing global operations of BioXcel &amp; its subsidiaries and helps evaluate &amp; build new opportunities.</p>
1057</div>
1058</div>
1059</div>
1060</div>
1061</div>
1062</div>
1063</div>
1064
1065<div aria-hidden="true" aria-labelledby="himani" class="modal fade team" id="Dean" tabindex="-1">
1066<div class="modal-dialog  modal-xl modal-dialog-centered">
1067<div class="modal-content ">
1068<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1069
1070<div class="container ptb20">
1071<div class="row">
1072<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team7.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1073
1074<div class="col-sm-8">
1075<h2 class="clrbl">David Dean</h2>
1076
1077<h5 class="clrbl">Chief Financial Officer</h5>
1078
1079<p>Dave joined BioXcel in September 2022 as the Chief Financial Officer of our parent company, BioXcel LLC. In this position, Dave will work with senior leadership and the board of directors in the development and execution of strategy to drive significant growth within our organization. Prior to joining BioXcel, Dave served as CFO at a Connecticut based medical device company, leading the sale of the company three times over a ten year span, each sale at significantly increased valuations. Dave has served in financial leadership positions over the past thirty years, focused on healthcare, life science instrumentation and medical devices. He started his professional career with the national accounting firm Arthur Andersen.</p>
1080</div>
1081</div>
1082</div>
1083</div>
1084</div>
1085</div>
1086</div>
1087
1088<div aria-hidden="true" aria-labelledby="himani" class="modal fade team" id="himani" tabindex="-1">
1089<div class="modal-dialog  modal-xl modal-dialog-centered">
1090<div class="modal-content ">
1091<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1092
1093<div class="container ptb20">
1094<div class="row">
1095<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team4.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1096
1097<div class="col-sm-8">
1098<h2 class="clrbl">Dr. Himani Sharma</h2>
1099
1100<h5 class="clrbl">VP, Corporate Strategy &amp; Innovation, BioXcel India</h5>
1101
1102<p>Dr. Himani Sharma is a marquee leader in developing first-in-class analytical tools and AI-based platforms at BioXcel. She adds more than 15 years of rich experience in strategic consulting, target and medication discovery, and the development of AI-based systems. She played a pivotal role in collaborations dealing with identification of novel druggable targets for drug development, the mapping of future prospects, and life cycle management through reformulation and repurposing utilising real-world data. At BioXcel, she oversees the scientific, clinical, commercial, information technology, and data science departments. She has been at the forefront of creating disease-specific algorithms to identify solutions that fulfil unmet requirements across major therapeutic areas. She holds a B.S., M.S., and Ph.D. in Biochemistry from the All India Institute of Medical Sciences in New Delhi, India, and has earned several accolades from organisations like UNESCO, IUBMB ASCB, and HUPO.</p>
1103</div>
1104</div>
1105</div>
1106</div>
1107</div>
1108</div>
1109</div>
1110
1111<div aria-hidden="true" aria-labelledby="demetrios" class="modal fade team" id="demetrios" tabindex="-1">
1112<div class="modal-dialog  modal-xl modal-dialog-centered">
1113<div class="modal-content ">
1114<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1115
1116<div class="container ptb20">
1117<div class="row">
1118<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team5.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1119
1120<div class="col-sm-8">
1121<h2 class="clrbl">Demetrios Kydonieus</h2>
1122
1123<h5 class="clrbl">R-Pharm U.S.</h5>
1124
1125<p>Mr. Kydonieus is the President and Chief Business Officer of R-Pharm U.S., based in Princeton, New Jersey, where he is accelerating the expansion and commercial infrastru
1125cture of Russia&#39;s premier pharmaceutical firm, R-Pharm CJSC, by acquiring and licencing speciality goods. Prior to joining R-Pharm US, he spent 15 years at Bristol Myers Squibb, where he was most recently Vice President of Strategy, Alliances, and Transactions. Mr. Kydonieus is a seasoned pharmaceutical executive with a diverse background in Business Development, Legal, Regulatory, and Compliance.</p>
1126</div>
1127</div>
1128</div>
1129</div>
1130</div>
1131</div>
1132</div>
1133
1134<div aria-hidden="true" aria-labelledby="peter" class="modal fade team" id="peter" tabindex="-1">
1135<div class="modal-dialog  modal-xl modal-dialog-centered">
1136<div class="modal-content ">
1137<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1138
1139<div class="container ptb20">
1140<div class="row">
1141<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team6.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div>
1142
1143<div class="col-sm-8">
1144<h2 class="clrbl">Peter Mueller, PH.D.</h2>
1145
1146<h5 class="clrbl">Chairman, Scientific Advisory Board</h5>
1147
1148<p>Dr. Peter Mueller is the President and Chief Scientific Officer of Axcella Health&#39;s Research &amp; Development department. He was previously the Executive Vice President of Global Research and Development and Chief Scientific Officer of Vertex Pharmaceuticals. At the time, he was in charge of Vertex&#39;s global drug discovery and development efforts. Under his esteemed supervision, INCIVEK&reg; (HepC) and KALYDECO&reg; (CF) were authorised and launched by the company in 2011 and 2012, respectively. In addition, Vertex filed an NDA and an MAA for ORKAMBI&reg; (CF). Dr. Mueller has also worked for Boehringer Ingelheim Pharmaceuticals, Inc. as Senior Vice President, Research and Development, where he was instrumental in the development of Spiriva&reg;, Combivent&reg;, and Atrovent&reg;. He is a member of the Gesellschaft Deutscher Chemiker (GDCh) and Verband Chemische Industrie (Germany), Royal Society of Chemistry (UK), IRI, RNA-Society, ASAP, AAAS (USA), and currently serves on several Boards and Scientific Advisory Boards in companies and organisations such as the US-India Chamber of Commerce Biotech, Pharma &amp; Medical Devices Council, University Iowa (CBB), Keystone Symposia, Inhibikase Therapeutics, Inc., and Kaleido Biosciences, Inc.</p>
1149</div>
1150</div>
1151</div>
1152</div>
1153</div>
1154</div>
1155</div>
1156<!--//team Management--><!--tech-->
1157
1158<div aria-hidden="true" aria-labelledby="tech" class="modal fade" id="techno" tabindex="-1">
1159<div class="modal-dialog  modal-xl modal-dialog-centered">
1160<div class="modal-content ">
1161<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button>
1162
1163<div class="container ptb20">
1164<div class="row">
1165<div class="col-sm-12">
1166<h2 class="clrbl">TECHNOLOGY</h2>
1167
1168<p>There is nothing more important than making people live healthy and longer lives. Check how BioXcel&rsquo;s AI platform is extending the gift of science to people.</p>
1169
1170<h2 class="clrbl">EvolverAI</h2>
1171
1172<p>By utilizing this powerful AI platform EvolverAI, BioXcel Therapeutics successfully developed the first candidate medicine, IGALMI&trade; (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Our company performed this task in a matter of four years. We ensured that this medicine reached the patients and addressed a significant unmet need among patients and caregivers.</p>
1173
1174<p>At BioXcel, we are constantly working towards significantly reducing the bottlenecks associated with drug development, and identifying safe and well tolerated drugs for humans. We take on this responsibility by utilizing our AI-based platform EvolverAI for maximizing time advantage. EvolverAI efficiently carries out the analysis of big data through its deep learning algorithms. Its purpose is to bring to life our vision of changing the landscape of pharmaceutical research and development (R&amp;D) by decoding therapeutic agents and disease biology. Our AI/ML algorithms are trained for model construction that aid in the identification of relevant repurposing prospects.</p>
1175
1176<p>Our platform is decoding many therapeutic possibilities of a drug compound by the unique combination of subject matter experts and AI platform. We are hopeful that with the help of our AI platform, we are only steps away from incredible innovations that will not only cut short the time, but also the costs and risks associated with drug development. This will eventually lead to expanding the pipeline of potentially life-saving drug discoveries</p>
1177</div>
1178</div>
1179</div>
1180</div>
1181</div>
1182</div>
1183</div>
1184<!--//tech--></body>
1185</html>

Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.